3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 261/00 (2006.01) A61K 31/41 (2006.01) A61K 31/44 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) A61K 31/675 (2006.01) C07C 205/51 (2006.01) C07D 261/04 (2006.01) C07D 261/08 (2006.01) C07D 261/20 (2006.01) C07D 413/02 (2006.01) C07D 413/04 (2006.01) C07D 413/12 (2006.01) C07D 417/04 (2006.01) C07F 9/653 (2006.01)

Patent

CA 2185004

A compound having the formula (I), a physiolog- ically tolerable salt of the compound having the formula (I) and/or a stereoisomeric form of the compound having the formula (I), in which one residue R1 or R2 stands for the formula (II), are suitable for preparing medicaments for the therapy of inflammation, asthma, rhematoid diseases and auto-immune diseases.

Un composé ayant la formule (I), un sel physiologiquement tolérable du composé ayant la formule (I) et/ou une forme stéréoisomère du composé ayant la formule (I), dans laquelle un résidu R<1> ou R<2> est représenté par la formule (II), sont utiles pour préparer des médicaments en vue du traitement des inflammations, de l'asthme, des maladies rhumatismales et des maladies auto-immunitaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1738041

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.